PMV Pharmaceuticals, Inc (PMVP)
PHARMACEUTICAL PREPARATIONS
PMV Pharmaceuticals, Inc (PMVP) is listed on Nasdaq, where it has traded since September 25, 2020.
- Listed On
- Nasdaq
- Listed Since
- September 25, 2020
- Employees
- 54
- Market Cap
- $71M
About PMV Pharmaceuticals, Inc
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 62 institutions reported holding PMVP, with 34.3 million shares worth $45.9 million in aggregate. The largest reported holder was Bml Capital Management, with 5.3 million shares worth $7.1 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Bml Capital Management | 5,330,000 | $7M | Added 0.19% |
| Tang Capital Management | 4,245,085 | $6M | Unchanged |
| Sio Capital Management | 2,634,137 | $4M | Reduced 14.38% |
| Euclidean Capital | 2,627,643 | $4M | Unchanged |
| Adage Capital Partners GP, | 2,360,000 | $3M | Added 26.88% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is PMVP?
PMV Pharmaceuticals, Inc (PMVP) is listed on Nasdaq, where it has traded since September 25, 2020.
Who are the largest institutional holders of PMVP?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of PMVP were Bml Capital Management, Tang Capital Management and Sio Capital Management.
How many institutions own PMVP?
62 institutions reported a position in PMVP for the quarter ended June 30, 2026, worth $45.9 million in total.
Did institutions buy or sell PMVP last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for PMVP.
Every reported institutional holder, plus insider and congressional trades in PMVP, on SentiSense.